Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 28, 2020CancersOpen Access

Cannabis Consumption Used by Cancer Patients during Immunotherapy Correlates with Poor Clinical Outcome

View Full Paper
Ask AI
Bookmark
Share

Authors

GBGil Bar‐SelaICIdan CohenSCSalvatore Campisi‐Pinto

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Bar‐Sela et al. (2020) studied this question.

synapsesocial.com/papers/6941cec76ff23261fafbb7aahttps://doi.org/10.3390/cancers12092447
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Immune Checkpoint Blockade in Cancer Therapy2015 · 2,782 citations
  2. 2The Anti-Inflammatory Properties of Terpenoids from Cannabis2018 · 110 citations
  3. 3Cannabinoid Receptor Type 1- and 2-mediated Increase in Cyclic AMP Inhibits T Cell Receptor-triggered Signaling2009 · 101 citations
  4. 4Molecular targets for cannabidiol and its synthetic analogues: effect on vanilloid VR1 receptors and on the cellular uptake and enzymatic hydrolysis of anandamide2001 · 1,320 citations